Background and objective
Spinal cord injury (SCI) is a major disabling disorder for which no effective treatment has yet been found. Regenerative incapability of neuronal cells as well as the secondary mechanisms of injury are the major reasons behind this clinical frustration. Thus, here we fabricated an erythropoietin-chitosan/alginate (EPO-CH/AL) hydrogel and investigated its local therapeutic effects on the apoptotic and inflammatory indices of SCI secondary injury.
EPO-CH/AL hydrogels were fabricated by the ionic gelation method, and they were characterized using SEM and FTIR. In vitro drug release profile of EPO-CH/AL hydrogels was evaluated by UV–vis spectroscopy. Experimental SCI was inflicted in rats which were then treated with CH/AL hydrogels containing different doses of EPO (1000, 5000 and 10,000 IU/kg). The relative expression of Bax and Bcl2 (apoptosis index) and active and inactive forms of NF-κB (inflammation index) were assessed using western blot. Total serum levels of TNF-α were also assessed with ELISA, and histopathological and immunohistochemistry studies were carried out to check the overall changes in the injured tissues.
In vitro drug release test indicated that the EPO-CH/AL hydrogels had a sustained- and controlled-release profile for EPO under these conditions. All the fabricated hydrogels dramatically reduced the elevated inflammation and apoptosis indices of the SCI-inflicted rats (p ≤ 0.05). Nevertheless, only EPO-CH/AL hydrogel (1000 IU/kg EPO) significantly improved the tissue repair and histopathological appearance of the spinal cord at the sites of injury.
Based on our findings, EPO-CH/AL hydrogel (1000 IU/kg EPO) can effectively improve experimental SCI in rats via inhibiting apoptosis and inflammation. Further studies are warranted to elucidate the contributing role of the scaffold in the observed effects.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price includes VAT (USA)
Tax calculation will be finalised during checkout.
Zhao Y, Zuo Y, Wang X, Huo H, Jiang J, Yan H, et al. Effect of neural stem cell transplantation combined with erythropoietin injection on axon regeneration in adult rats with transected spinal cord injury. Genet Mol Res. 2015;14:17799–808.
Kaptanoglu E, Solaroglu I, Okutan O, Surucu HS, Akbiyik F, Beskonakli E. Erythropoietin exerts neuroprotection after acute spinal cord injury in rats: Effect on lipid peroxidation and early ultrastructural findings. Neurosurg Rev. 2004;27(2):113–20.
Li J, Guo W, Xiong M, Zhang S, Han H, Chen J, et al. Erythropoietin facilitates the recruitment of bone marrow mesenchymal stem cells to sites of spinal cord injury. Exp Ther Med. 2017;13(5):1806–12.
Matis GK, Birbilis TA. Erythropoietin in spinal cord injury. Eur Spine J. 2009;18(3):314–23.
Carelli S, Marfia G, Di Giulio AM, Ghilardi G, Gorio A. Erythropoietin: Recent developments in the treatment of spinal cord injury. Neurol Rest In. 2011;2011.
Bustos ML, Huleihel L, Kapetanaki MG, Lino-Cardenas CL, Mroz L, Ellis BM, et al. Aging mesenchymal stem cells fail to protect because of impaired migration and antiinflammatory response. Am J Respir Crit Care Med. 2014;189(7):787–98.
Fehlings MG, Wilson JR, Cho N. Methylprednisolone for the treatment of acute spinal cord injury: counterpoint. Neurosurgery. 2014;61(Suppl 1):36–42.
Ozkunt O, Sariyilmaz K, Gemalmaz HC, Gürgen SG, Yener U, Dikici F. Investigation of efficacy of treatment in spinal cord injury: Erythropoietin versus methylprednisolone. J Orthop Surg. 2017;25(3):2309499017739481.
Boran BO, Colak A, Kutlay M. Erythropoietin enhances neurological recovery after experimental spinal cord injury. Restor Neurol Neurosci. 2005;23(5–6):341–5.
Vitellaro-Zuccarello L, Mazzetti S, Madaschi L, Bosisio P, Fontana E, Gorio A, et al. Chronic erythropoietin-mediated effects on the expression of astrocyte markers in a rat model of contusive spinal cord injury. Neuroscience. 2008;151(2):452–66.
Zhou Y, Su P, Pan Z, Liu D, Niu Y, Zhu W, et al. Combination Therapy With Hyperbaric Oxygen and Erythropoietin Inhibits Neuronal Apoptosis and Improves Recovery in Rats With Spinal Cord Injury. Phys Ther. 2019;99(12):1679–89.
King VR, Averill SA, Hewazy D, Priestley JV, Torup L, Michael-Titus AT. Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat. Eur J Neurosci. 2007;26(1):90–100.
Hong Z, Hong H, Chen H, Wang Z, Hong D. Protective effects of erythropoietin in experimental spinal cord injury by reducing the C/EBP-homologous protein expression. Neurol Res. 2012;34(1):85–90.
Utada K, Ishida K, Tohyama S, Urushima Y, Mizukami Y, Yamashita A, et al. The combination of insulin-like growth factor 1 and erythropoietin protects against ischemic spinal cord injury in rabbits. J Anesth. 2015;29(5):741–8.
Chen SQ, Xu YJ, Yu C, Hao YM, Zhang ZD, Gu YP. Protective effect of erythropoietin on neurocyte apoptosis following experimental acute spinal cord injury in rats. Journal of Clinical Rehabilitative Tissue Engineering Research. 2008;12(11):2034–8.
Li J, Guo W, Xiong M, Han H, Chen J, Mao D, et al. Effect of SDF-1/CXCR4 axis on the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward lesion sites following spinal cord injury. Int J Mol Med. 2015;36(5):1205–14.
Zhao Y, Xiao Y, Zuo Y, Wang X, Huo H, Jiang J, et al. Repair effect of neural stem cells transplantation combined with erythropoietin on spinal cord injury in rats. Journal of Jilin University Medicine Edition. 2015;41(2):333–7.
Zhang H, Fang X, Huang D, Luo Q, Zheng M, Wang K, et al. Erythropoietin signaling increases neurogenesis and oligodendrogenesis of endogenous neural stem cells following spinal cord injury both in vivo and in vitro. Mol Med Rep. 2018;17(1):264–72.
Zhao Y, Zuo Y, Jiang J, Yan H, Wang X, Huo H, et al. Neural stem cell transplantation combined with erythropoietin for the treatment of spinal cord injury in rats. Exp Ther Med. 2016;12(4):2688–94.
Nekoui A, Tresierra VDCE, Abdolmohammadi S, Shedid D, Blaise G. Neuroprotective effect of erythropoietin in postoperation cervical spinal cord injury: case report and review. Anesthesiology and pain medicine. 2015;5(6).
Hashimoto T, Suzuki Y, Suzuki K, Nakashima T, Tanihara M, Ide C. Review Peripheral nerve regeneration using non-tubular alginate gel crosslinked with covalent bonds. J Mater Sci - Mater Med. 2005;16(6):503–9.
Deng B, Shen L, Wu Y, Shen Y, Ding X, Lu S, et al. Delivery of alginate-chitosan hydrogel promotes endogenous repair and preserves cardiac function in rats with myocardial infarction. J Biomed Mater Res - Part A. 2015;103(3):907–18.
Barros AGCd, Cristante AF, Santos GBd, Natalino RJM, Ferreira RJR, Barros-Filho TEPd. Evaluation of the effects of erythropoietin and interleukin-6 in rats submitted to acute spinal cord injury. Clinics. 2019;74.
Tawfik S, Abd Elsalam S, El-Hennawi H, Abd El-Thalouth I, Adel E, editors. Synthesis of partially carboxymethyl cellulose derived from rice straw and its utilization as dye adsorbent. International Conference on Applied Life Sciences. 2012: IntechOpen.
Sadiq A, Choubey A, Bajpai A. Biosorption of chromium ions by calcium alginate nanoparticles. J Chil Chem Soc. 2018;63(3):4077–81.
Liu Q, Li Q, Xu S, Zheng Q, Cao X. Preparation and properties of 3D printed alginate–chitosan Polyion complex hydrogels for tissue engineering. Polymers. 2018;10(6):664.
Lustriane C, Dwivany FM, Suendo V, Reza M. Effect of chitosan and chitosan-nanoparticles on post harvest quality of banana fruits. J Plant Biotechnol. 2018;45(1):36–44.
Li Z, Ramay HR, Hauch KD, Xiao D, Zhang M. Chitosan–alginate hybrid scaffolds for bone tissue engineering. biomaterials. 2005;26(18):3919–28.
Baysal K, Aroguz AZ, Adiguzel Z, Baysal BM. Chitosan/alginate crosslinked hydrogels: Preparation, characterization and application for cell growth purposes. Int J Biol Macromol. 2013;59:342–8.
Wang G, Wang X, Huang L. Feasibility of chitosan-alginate (Chi-Alg) hydrogel used as scaffold for neural tissue engineering: a pilot study in vitro. Biotechnol Biotechnol Equip. 2017;31(4):766–73.
Özdemir B, Batçık E, Ayçiçek E, Canaz G, Akdemir O, Alataş İ, et al. Investigation of dose-dependent neuroprotective effect of human recombinant erythropoietin in acute spinal cord injury induced rats. Int J Clin Exp Med. 2016;9(3):6385–93.
Zhao Y, Ding W, Zhang W. The study of the effect of erythropoietin on motor function of hind limbs and the expression of NF-κB after acute spinal cord injury in rats. Chinese J Rehabilitation Med. 2007;22(10):904–7.
Cheng M, Cao W, Gao Y, Gong Y, Zhao N, Zhang X. Studies on nerve cell affinity of biodegradable modified chitosan films. J Biomater Sci Polym Ed. 2003;14(10):1155–67.
Cho Y, Shi R, Borgens RB. Chitosan produces potent neuroprotection and physiological recovery following traumatic spinal cord injury. J Exp Biol. 2010;213(9):1513–20.
Jian R, Yixu Y, Sheyu L, Jianhong S, Yaohua Y, Xing S, et al. Repair of spinal cord injury by chitosan scaffold with glioma ECM and SB 216763 implantation in adult rats. J Biomed Mater Res, Part A. 2015;103(10):3259–72.
Zhang W, Zhu X, Zhang D. Transplantation of bone marrow mesenchymal stem cells overexpressing Shootin1 for treatment of spinal cord injury. Chinese J Tissue Eng Res. 2016;20(50):7507–17.
Zhang H, Zheng H, Zhang Q, Wang J, Konno M. The interaction of sodium alginate with univalent cations. Biopolymers: Original Research on Biomolecules. 1998;46(6):395–402.
Wang C-C, Yang K-C, Lin K-H, Liu H-C, Lin F-H. A highly organized three-dimensional alginate scaffold for cartilage tissue engineering prepared by microfluidic technology. Biomaterials. 2011;32(29):7118–26.
Prang P, Müller R, Eljaouhari A, Heckmann K, Kunz W, Weber T, et al. The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. Biomaterials. 2006;27(19):3560–9.
Okutan O, Solaroglu I, Beskonakli E, Taskin Y. Recombinant human erythropoietin decreases myeloperoxidase and caspase-3 activity and improves early functional results after spinal cord injury in rats. J Clin Neurosci. 2007;14(4):364–8.
Costa DD, Beghi E, Carignano P, Pagliacci C, Faccioli F, Pupillo E, et al. Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP). Neurol Sci. 2015;36(9):1567–74.
This research received no specific grant from any funder.
Conflicts of interest
The authors have no conflicts of interest to declare.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Gholami, M., Gilanpour, H., Sadeghinezhad, J. et al. Facile fabrication of an erythropoietin-alginate/chitosan hydrogel and evaluation of its local therapeutic effects on spinal cord injury in rats. DARU J Pharm Sci 29, 255–265 (2021). https://doi.org/10.1007/s40199-021-00399-4
- Spinal cord injury